Found: 8
Select item for more details and to access through your institution.
Effects of benfluorex on fatty acid and glucose metabolism in isolated rat hepatocytes: from metabolic fluxes to gene expression.
- Published in:
- 2002
- By:
- Publication type:
- journal article
Insulin release from isolated islets of Langerhans after segmental-pancreas autotransplantation in dogs.
- Published in:
- 1989
- By:
- Publication type:
- journal article
Correction to: Bumetanide Oral Liquid Formulation for the Treatment of Children and Adolescents with Autism Spectrum Disorder: Design of Two Phase III Studies (SIGN Trials).
- Published in:
- 2021
- By:
- Publication type:
- Correction Notice
Bumetanide Oral Liquid Formulation for the Treatment of Children and Adolescents with Autism Spectrum Disorder: Design of Two Phase III Studies (SIGN Trials).
- Published in:
- Journal of Autism & Developmental Disorders, 2021, v. 51, n. 8, p. 2959, doi. 10.1007/s10803-020-04709-8
- By:
- Publication type:
- Article
Bumetanide oral solution for the treatment of children and adolescents with autism spectrum disorder: Results from two randomized phase III studies.
- Published in:
- Autism Research: Official Journal of the International Society for Autism Research, 2023, v. 16, n. 10, p. 2021, doi. 10.1002/aur.3005
- By:
- Publication type:
- Article
Differential effects of sulphonylureas on the vasodilatory response evoked by KATP channel openers.
- Published in:
- Fundamental & Clinical Pharmacology, 2003, v. 17, n. 1, p. 61, doi. 10.1046/j.1472-8206.2003.00144.x
- By:
- Publication type:
- Article
A Double‐Blind, Randomized, Placebo‐Controlled Trial of Bumetanide in Parkinson's Disease.
- Published in:
- Movement Disorders, 2024, v. 39, n. 3, p. 618, doi. 10.1002/mds.29726
- By:
- Publication type:
- Article
A Phase III Study of Bumetanide Oral Liquid Formulation for the Treatment of Children and Adolescents Aged Between 7 and 17 Years with Autism Spectrum Disorder (SIGN 1 Trial): Participant Baseline Characteristics.
- Published in:
- Child Psychiatry & Human Development, 2023, v. 54, n. 5, p. 1360, doi. 10.1007/s10578-022-01328-5
- By:
- Publication type:
- Article